MediciNova Inc's (NASDAQ: MNOV) collaborators presented new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) patients at the Annual Meeting of the
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the
Friday, the FDA approved Medtronic plc's (NYSE: MDT) Symplicity Spyral renal denervation (RDN) system, also known as the Symplicity blood pressure procedure, for hypertension or
Alzamend Neuro Inc (NASDAQ: ALZN) has received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for